Kerala DC Dept Seizes Unauthorized Stock Of AstraZeneca’s Breast Cancer Drug, Zoladex LA Worth Over Rs. 11 Lakh

Chennai : The sleuths of the special intelligence branch of the Kerala drugs control department has raided and seized illegal stock of imported breast cancer drug, Zoladex LA 10.8 mg, worth Rs. 11,55, 600, from a wholesaler’s premises in the state capital.

The seized injectable drugs, Goserelin Acetate Depot Injection, branded under Zoladex LA, are imported products from the United Kingdom.

The injection formulation is manufactured by the UK based MNC, AstraZeneca, and is marketed in India by its marketing company, AstraZeneca Pharma Private Ltd in Bengaluru.

“Zoladex LA, a brand of AstraZeneca, is not permitted to be stocked by private vendors and strictly restricted for retail sale. It is authorized for distribution to the neediest patients through government hospitals only. However, there are distributors who got special approval from the health department for government supply and are permitted to stock this formulation in a licensed premises”, said M K Geetha, drug inspector in the intelligence wing, who led the operation.

She said private medical shops cannot stock this medicine for government supply without authorization. The stockist at Thiruvananthapuram could not produce any government authorization to the investigating officials. Action has been initiated against the dealer as per Section 65 (18) of the Drugs and Cosmetics Act.

It is learnt that, on prima facie, the enforcement officials of the drugs control department could not find any proof of government approval for stock of the medicine in the wholesaler’s premises. More investigation is going on, said Jayan Menon, state drugs controller.

He said the department has served a notice to AstraZeneca seeking proof of supply of the items to the dealer in Thiruvananthapuram.   The products were seized from the godown of ‘Karunyam Pharmacare’ at Murinjapalam in the capital city. All the seized products were produced before the additional CJM court. The unit MRP of the formulation is Rs. 28,890.

Briefing Pharmabiz, Jayan Menon said the drug is only for government supply and cannot be sold privately. Medical shops are not permitted to sell the products. Its label contains the warning “only for government sale”. Somehow the department got information from sources about the sale of the drug through the medical shop. Immediately the department officials launched a crackdown on the private pharmacy and seized all the stocked items and legal actions were initiated.

  • Related Posts

    • Pharma
    • December 23, 2024
    • 73 views
    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    India’s healthcare and pharmaceutical sectors raised Rs 14,811 crore through initial public offerings (IPOs) in 2024, the largest since 2019, driven by strong domestic demand amid expanding global opportunities. According…

    • Pharma
    • December 23, 2024
    • 107 views
    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 65 new drug formulations and notified ceiling price fixation of 13 formulations. The regulatory body, under the Department of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    Healthcare, pharma sectors raise Rs 14,811 crore via IPOs in 2024

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    NPPA sets retail prices for 65 drugs, revises ceiling for 20 formulations

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    India-Latin America trade and collaboration prospects discussed at Kerala University conference

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    Karnataka Govt Files Criminal Cases Against Pharma Firm In Ballari Maternal Deaths Case

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    NPPA Notifies Ceiling Price Of 13 Formulations, Retail Price Of 65 New Drugs

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt

    Over 14,000 PMBJK Centres Set Up To Provide Generic Medicines: Govt